XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Details (Tables)

Condensed Consolidated Financial Statements Details (Tables)

9 Months Ended

Sep. 30, 2022

Condensed Consolidated Financial Statements Details

Schedule of accrued and other liabilities

Accrued and other liabilities consisted of the following (in thousands):


	September 30,		December 31,
	2022		2021
Accrued legal and accounting fees		555		295
Accrued incentive compensation		461		55
Accrued payroll and benefits		162		135
Other accrued liabilities		30		40
Total	$	1,208	$	525

Schedule of reconciliation of numerator and denominator used in calculation of basic and diluted net (loss) per share available to common stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Numerator
Net loss	$	(4,178)	$	(4,436)	$	(11,128)	$	(14,046)
Less: Series A accumulated dividends		(530)		(530)		(1,591)		(1,591)
Less: Series B accumulated dividends		(838)		(838)		(2,513)		(1,601)
Net loss attributable to common stockholders, basic and diluted	$	(5,546)	$	(5,804)	$	(15,232)	$	(17,238)

Denominator
Weighted average shares used in computing basic and diluted net loss per share attributable to common stockholders		11,447		11,311		11,400		11,279
Basic and diluted net loss per share attributable to common stockholders	$	(0.48)		(0.51)	$	(1.34)	$	(1.53)

Schedule of outstanding securities considered anti-dilutive

The following table shows the weighted-average shares from outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):


	Three Months Ended September 30,		Nine Months Ended September 30,
	2022	2021	2022	2021
Convertible preferred stock	5,003	5,003	5,003	5,003
Common stock options	888	505	831	362
Warrants for common stock	6	4	6	5
Total	5,897	5,512	5,840	5,370